Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Test for Mad Cow Disease

By HospiMedica staff writers
Posted on 27 Apr 2004
A new rapid test for bovine spongiform encephalopathy (BSE), also known as mad cow disease, has been cleared by the U.S. More...
Food and Drug Administration (FDA).

The test, which detects the presence of the abnormal prions believed to cause BSE, was developed by Enfer Scientific, Ltd. (Newbridge, Ireland). The company entered into a marketing and distribution agreement in 2001 with Abbott Laboratories (Abbott Park, IL, USA), which gave the Abbott exclusive rights to sell the test throughout the world except in Ireland. The test has been approved for cattle testing in the European Union and Japan. The rapid test provides results within hours, is easy to use, and meets the workflow needs of the screening laboratories approved by the United States Department of Agriculture (USDA).

"The rapid Enfer BSE assay tests every bovine brain sample in duplicate,” said Jim Koziarz, Ph.D., vice president, research and development, diagnostics, Abbot Laboratories. "If either test result is reactive, the brain specimen is resampled and retested in duplicate. This type of testing method ensures that a true positive would be reliably detected.”

Enfer Scientific is the world's largest screening laboratory for transmissible spongiform encephalopathies (TSEs) using the Enfer test. The company routinely performs up to 9,000 tests per day, providing results to beef processors within a minimum turnaround time of 12 hours. Prior to the approval of rapid BSE tests, the USDA used an immunohistochemistry BSE test that took several days to perform and report the results.


Related Links:
Enfer Scientific
Abbott Labs

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.